Valentin Stalf & Maximilian Tayenthal, CEO & COO
Earlybird played a crucial role in shaping our vision and market strategy, especially during our Seed and Series A stages They have proven to be enormously valuable sparring partners
As everyone would expect, with Earlybird we had access to "the way of the unicorn" – since they were early stage investors in UiPath and we could learn a lot from them Perhaps less obvious is the support we continuously got – feedback on strategy and business ideas, relevant intros to thought leaders and business practitioners, and full support during the initial uncertain times of the pandemic
I have received fantastic support from the Earlybird team Whether for financing purposes, operational issues or strategy, their polyvalent healthcare team has always been there for Miracor They provide relevant input and always remain solution-oriented It has been — and continues to be — a pleasure to have them as a key investor
Roland has been an extremely helpful member of the Hazelcast team His background as a business operator comes forth in the most constructive of ways, as does his personal network and that of the entire Earlybird team
Earlybird is a venture capital investor focused on European technology innovators
Founded in 1997, Earlybird invests in all development and growth phases of technology companies Among the most experienced venture investors in Europe, Earlybird offers its portfolio companies not only financial resources but also strategic support plus access to an international network and capital markets
Earlybird Venture Capital has grown to four autonomous, dedicated and specialized teams, focusing on different geographies and sectors
The Digital West Fund focuses primarily on early stage digital technology opportunities in GSA, Nordics, UK, Benelux, France and Southern Europe, while the Digital East Fund is focused on early stage ICT investment opportunities in Eastern Europe and Turkey, being the leading tech VC in this region The Health Fund focuses on early and later stage opportunities in digital health, medical devices, diagnostics, enabling technologies and biopharma across Europe Earlybird-X backs deep tech innovation, including robotics, AI, and mobility, at the earliest stages – tapping into a network of leading European universities
With EUR 2 billion under management across all fund streams, eight IPOs and 30 trade sales, Earlybird is one of the most established and active venture capital firms in Europe Beyond delivering financial returns, we clearly see our own entrepreneurial responsibility for the environment as well as society and strive to make a positive contribution towards solving the global climate crisis We are committed to running our own operations in a more eco-sustainable way and offset the residual carbon-footprint while expecting the same from our portfolio companies
BILLION EUROS OF ASSETS UNDER MANAGEMENT INVESTMENTS IN THE LAST 12 MONTHS THOUSAND EUROS AS LOWEST INVESTMENT MILLION EUROS AS HIGHEST INVESTMENT